Kuano
Company

Last deal

$1.37M
Local Amount - GBP 1.8M

Amount

Seed

Stage

12.09.2023

Date

3

all rounds

$2.13M

Total amount

date founded

Financing round

General

About Company
Kuano offers quantum and AI solutions for drug discovery and design.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Last funding type

Seed

IPO status

Private

Description

The company's platform combines quantum physics, AI, and medicinal chemistry to develop better drug candidates faster. Kuano's unique approach targets quantum transition states, introducing selectivity from the start and eliminating bottlenecks in the hit to candidate optimization phase. This strategy significantly improves the quality of new drugs being produced while reducing discovery time. Kuano works with leading academics and providers in the fields of quantum computing, AI, and machine learning and is interested in drug discovery collaborations with pharmaceutical and biotech companies seeking new approaches to novel, first in class, best in class, or next-generation inhibitors for validated or intractable enzyme targets.
Contacts

location

Contact Email

Social url

Legal Names

Legal name

Kuano Ltd.
Similar Companies
1000
Iktos

Iktos

Iktos is a start-up that uses artificial intelligence to develop optimized molecules for drug discovery.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Paris, France

total rounds

4

total raised

$16.36M
Valence Discovery

Valence Discovery

Valence Discovery is an AI-first company that designs novel chemistry against previously intractable biology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Machine Learning, Software

Location

Dorval, QC, Canada

total rounds

5

total raised

$8.51M
Galux

Galux

Galux is a company that uses AI-based drug design platform technologies to develop novel drugs for incurable and rare diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Dogok-dong, Gangnam-gu, Seoul, South Korea

total rounds

1
Exscientia

Exscientia

Exscientia is an AI-driven pharma tech company that uses big data processing to accelerate drug discovery and development.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Artificial Intelligence, News

Location

Oxford, UK

total rounds

10

total raised

$471.73M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$2.13M

Money Raised

Their latest funding was raised on 12.09.2023. Their latest investor Ascension Ventures. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
12.09.2023
5
$1.37M
Local Amount - GBP 1.8M
08.07.2021
2
$761.66K
Local Amount - GBP 1M
Mercia Fund Managers

Mercia Fund Managers

Mercia Fund Managers provides venture capital for early-stage tech start-ups in West Midlands.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Finance

Location

Henley-in-Arden B95, UK

total rounds

1

total raised

$32.13M

count Of Investments

140

count Of Exists

12
O2h Ventures

O2h Ventures

O2h Ventures is a UK-based investment firm that focuses on backing biotech through tax-efficient EIS and SEIS investments.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Venture Capital, Financial Services

count Of Investments

36
ACF Investors

ACF Investors

The Angel CoFund co-invests with Angel investors to fund and scale high-potential early-stage businesses.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Sheffield, UK

count Of Investments

122

count Of Exists

11
Creative Destruction Lab (CDL)

Creative Destruction Lab (CDL)

Creative Destruction Lab (CDL) is a no-fee/no-equity mentoring program for pre-seed stage ventures.

Sector

Industrial Support Services

Subsector

Professional Business Support Services

Keywords

Financial Services

Location

Toronto, ON, Canada

total rounds

5

total raised

$31.47M

count Of Investments

734

count Of Exists

41
Co-Investors
Investors
8
5

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
Ascension Ventures

Ascension Ventures

Ascension is an early-stage venture capital firm backing tech and impact founders.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Venture Capital, Therapeutics

Location

Clarkton, MO 63837, USA

count Of Investments

86

count Of Exists

24
ACF Investors

ACF Investors

The Angel CoFund co-invests with Angel investors to fund and scale high-potential early-stage businesses.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Sheffield, UK

count Of Investments

122

count Of Exists

11
Timothy Mills

Timothy Mills

Tim is an Investment Director at the newly formed British Business Bank and also leads the investment activity and operations of the Angel CoFund. Tim started his career with Merrill Lynch, joining their graduate leadership programme to spend several years working in Europe, North America and Asia. Tim became an Associate Vice President in the technology group at Merrill before moving to Barclays Capital to work on the integration of the firm's expanding global operations. In the past Tim has worked with a leading credit analytics consultancy and one of the UKs largest hedge funds.Prior to the creation of the British Business Bank, Tim spent 5 years with Capital for Enterprise, leading investments into venture capital funds as well as launching various funds, including the Angel CoFund. Tim has a B.Sc. in Business and Technology and holds a full-time MBA from Manchester Business School.

current job

ACF Investors
ACF Investors

organization founded

1
O2h Ventures

O2h Ventures

O2h Ventures is a UK-based investment firm that focuses on backing biotech through tax-efficient EIS and SEIS investments.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Venture Capital, Financial Services

count Of Investments

36

People

Founders
4
David Wright
David Wright

David Wright

David Wright is the CTO and Founder of Kuano.

current job

Kuano
Kuano

organization founded

1

David Wright

Vid Stojevic
Vid Stojevic

Vid Stojevic

Vid has spent the past 10 years working on string theory and tensorial methods in quantum physics and has held postdocs at UCL and the University of Vienna with pioneers in these fields. He has publications in numerous high impact journals.

current job

Kuano
Kuano

organization founded

2

Vid Stojevic

Jarryl D'Oyley
Jarryl D'Oyley

Jarryl D'Oyley

Jarryl D'Oyley is the co-founder and medical chemist at Kuano.Jarryl D'Oyley attended UCL.

current job

Kuano
Kuano

organization founded

1

Jarryl D'Oyley

Parminder Ruprah
Parminder Ruprah

Parminder Ruprah

Parminder Ruprah is the Co-Founder and Head of Chemistry at Kuano. Parminder Ruprah attended University of Bath.

current job

Kuano
Kuano

organization founded

1

Parminder Ruprah

Employee Profiles
4
Jarryl D'Oyley

Jarryl D'Oyley

Co-Founder & Medicinal Chemist

David Wright

David Wright

Co-Founder & Medicinal Chemist

Parminder Ruprah

Parminder Ruprah

Co-Founder and Head of Chemistry

Vid Stojevic

Vid Stojevic

Co-Founder and CEO

Activity

Recent News
2